340 related articles for article (PubMed ID: 30590198)
1. Exploring the multicomponent synergy mechanism of Banxia Xiexin Decoction on irritable bowel syndrome by a systems pharmacology strategy.
Li B; Rui J; Ding X; Yang X
J Ethnopharmacol; 2019 Apr; 233():158-168. PubMed ID: 30590198
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the multicomponent synergy mechanisms of SiNiSan prescription on irritable bowel syndrome using a bioinformatics/network topology based strategy.
Li B; Rui J; Ding X; Chen Y; Yang X
Phytomedicine; 2019 Oct; 63():152982. PubMed ID: 31299593
[TBL] [Abstract][Full Text] [Related]
3. Using ultra-performance liquid chromatography with linear ion trap-electrostatic field orbitrap mass spectrometry, network pharmacology, and molecular docking to explore the constituent targets and action mechanisms of decoction of Angelica sinensis, Zingiberis Rhizoma Recens, and Mutton in the treatment of diarrhea-predominant irritable bowel syndrome.
Liu Z; Zheng Z; Wang T; Liu Z; Zuo Z
J Pharm Pharmacol; 2024 May; 76(5):462-478. PubMed ID: 37832514
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the synergistic network regulation of active components from SiNiSan against irritable bowel syndrome via a comprehensive strategy: Combined effects of synephrine, paeoniflorin and naringin.
Cai T; Wang X; Li B; Xiong F; Wu H; Yang X
Phytomedicine; 2021 Jun; 86():153527. PubMed ID: 33845366
[TBL] [Abstract][Full Text] [Related]
5. Identifying the active compounds and mechanism of action of Banxia Xiexin decoction for treating ethanol-induced chronic gastritis using network pharmacology combined with UPLC-LTQ-Orbitrap MS.
Ji W; Wang T; Xu Y; An R; Liang K; Wang X
Comput Biol Chem; 2021 Aug; 93():107535. PubMed ID: 34217946
[TBL] [Abstract][Full Text] [Related]
6. [Potential molecular mechanism of Banxia Xiexin Decoction in treatment of colon cancer based on network pharmacology and molecular docking technology].
Luo YT; Lin LF; Liu YL; Shi GL; Wu YQ; Yang AH; Li H
Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(23):5753-5761. PubMed ID: 33496116
[TBL] [Abstract][Full Text] [Related]
7. The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies.
Chen Y; Chu F; Lin J; Su Z; Liao M; Li T; Li Y; Johnson N; Zheng H; Ding X
J Ethnopharmacol; 2021 Jul; 275():114119. PubMed ID: 33862102
[TBL] [Abstract][Full Text] [Related]
8. Exploring the therapeutic mechanism of Banxia Xiexin Decoction in mild cognitive impairment and diabetes mellitus: a network pharmacology approach.
Li C; Yang W; Meng Y; Feng L; Sun L; Li Z; Liu X; Li M
Metab Brain Dis; 2023 Oct; 38(7):2315-2325. PubMed ID: 37556042
[TBL] [Abstract][Full Text] [Related]
9. Exploration of the potential mechanism of Banxia Xiexin Decoction for the effects on TNBS-induced ulcerative colitis rats with the assistance of network pharmacology analysis.
Wang W; Xu C; Li X; Wang Z; Yang J; Shen Y; Shi M; Chen L; Zhang L; Guo Y; Wang B; Zhang T; Pu Y
J Ethnopharmacol; 2021 Sep; 277():114197. PubMed ID: 34004261
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the pharmacological mechanism of Banxia Xiexin decoction in treating depression and ulcerative colitis based on a biological network module.
Yu Y; Zhang G; Han T; Huang H
BMC Complement Med Ther; 2020 Jun; 20(1):199. PubMed ID: 32600331
[TBL] [Abstract][Full Text] [Related]
11. Effect and mechanism of Banxia Xiexin decoction in colorectal cancer: A network pharmacology approach.
Wang Y; Zhao T; Huang C; Liu F; Zhang Y; Kong D; Fan Z
Phytomedicine; 2024 Jan; 123():155174. PubMed ID: 38039904
[TBL] [Abstract][Full Text] [Related]
12. Exploring the potential targets of Biling Weitong Granules on visceral hypersensitivity through integration of network pharmacology and in vivo analysis.
Yang Q; Zhao Y; Zhao X; Sun S; Chen Y; Chen J; Zou D; Zhang L
J Ethnopharmacol; 2023 Nov; 316():116701. PubMed ID: 37257703
[TBL] [Abstract][Full Text] [Related]
13. Banxia Xiexin decoction ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis via inhibiting serine-threonine protein kinase (Akt)/mitogen-activated protein kinase (MAPK) signaling pathway.
Ji W; Liu W; Huo Y; Hu C; Zhang Y
Biotechnol Appl Biochem; 2023 Aug; 70(4):1530-1542. PubMed ID: 36806191
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Banxia Xiexin Decoction Underlying Chronic Atrophic Gastritis via Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations.
Chang C; Feng W; Sun M; Yu X; Sun Z
Comput Math Methods Med; 2022; 2022():4237040. PubMed ID: 36158124
[TBL] [Abstract][Full Text] [Related]
15. Study on the Mechanisms of Banxia Xiexin Decoction in Treating Diabetic Gastroparesis Based on Network Pharmacology.
Wu T; Yue R; Li L; He M
Interdiscip Sci; 2020 Dec; 12(4):487-498. PubMed ID: 32914205
[TBL] [Abstract][Full Text] [Related]
16. Network pharmacology and molecular docking reveal the immunomodulatory mechanism of rhubarb peony decoction for the treatment of ulcerative colitis and irritable bowel syndrome.
Zhai L; Yang W; Li D; Zhou W; Cui M; Yao P
J Pharm Pharm Sci; 2023; 26():11225. PubMed ID: 37305432
[No Abstract] [Full Text] [Related]
17. A Network Pharmacology-Based Study on Irritable Bowel Syndrome Prevention and Treatment Utilizing Shenling Baizhu Powder.
Meng M; Bai C; Wan B; Zhao L; Li Z; Li D; Zhang S
Biomed Res Int; 2021; 2021():4579850. PubMed ID: 34859100
[TBL] [Abstract][Full Text] [Related]
18. Banxia Xiexin Decoction () Treats Diabetic Gastroparesis through PLC-IP
Wang B; Zeng KW; Hong ZF; Ti GX; Wang LY; Lu P; Liu Z
Chin J Integr Med; 2020 Nov; 26(11):833-838. PubMed ID: 32418177
[TBL] [Abstract][Full Text] [Related]
19. Exploring the synergistic pharmacological mechanism of Huoxiang Drink against irritable bowel syndrome by integrated data mining and network pharmacology.
Wang RH; Lin YK; Xie HK; Li H; Li M; He D
Medicine (Baltimore); 2023 Sep; 102(39):e35220. PubMed ID: 37773835
[TBL] [Abstract][Full Text] [Related]
20. Identification of the bioactive components of Banxia Xiexin Decoction that protect against CPT-11-induced intestinal toxicity via UPLC-based spectrum-effect relationship analyses.
Shi JW; Li ZZ; Wu JS; Jin WY; Chang XY; Sun H; Dong L; Jiang ZP; Shi Y
J Ethnopharmacol; 2021 Feb; 266():113421. PubMed ID: 33022337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
